This Undervalued Stock May Be Just What the Doctor Ordered

Now watching

Next video starts in : 7 Play

This Undervalued Stock May Be Just What the Doctor Ordered

This Undervalued Stock May Be Just What the Doctor Ordered
Replay video
Up next

Baxter's Spin-Off Strategy Is Promising

Unlock your personal NFL Now stream by signing in to NFL.com

This Undervalued Stock May Be Just What the Doctor Ordered

by Morningstar 1:10 mins

With Big Pharma shifting its drug development toward a strategic-partnership model, wide-moat Icon PLC's scale makes it one of the few companies capable of bidding on and winning these new contracts.

View Comments (4)